Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified Health Condition 2: C109- Malignant neoplasm of oropharynx,unspecified
Conditions
Interventions
Intervention1: Bovine Colostrum: BOVINE COLOSTRUM capsule (Trade Name: Trumcard) 500mg twice day daily for three consecutive months will be given to 20 selected patients.
Intervention2: Nigella Sativa
Sponsors
SEED MONEY GRANT TMU
Eligibility
Inclusion criteria
Inclusion criteria: All the patients who will be clinically diagnosed with Oral Submucous Fibrosis.
Exclusion criteria
Exclusion criteria: Patients allergic to Bovine Colostrum and Nigella Sativa
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To check the efficacy of Bovine colostrum in management of OSMF. To analyze the efficacy of Nigella Sativa in management of OSMF To compare the efficacy of both groupsTimepoint: Recall/follow up appointments will be after 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess if Bovine Colostrum and Nigella Sativa could be used as a treatment method for oral submucous fibrosisTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactUpender Malik
Teerthanker Mahaveer Dental College and Research Centre
Outcome results
None listed